Rectal Neuroendocrine Tumor Clinical Trial
Official title:
Cap Endoscopic Mucosal Resection(EMR-C) Versus Endoscopic Submucosal Dissection(ESD) for Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm
Verified date | June 2019 |
Source | Nanfang Hospital of Southern Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cap-assisted endoscopic mucosal resection (EMR-C) and endoscopic submucosal dissection (ESD) have both been reported to be effective treatment methods for small rectal neuroendocrine tumor (NET) in limited studies. Which one is better has not been determined. We aimed to compare the efficacy and safety of EMR-C and ESD for the treatment of small rectal NET.
Status | Not yet recruiting |
Enrollment | 90 |
Est. completion date | December 20, 2021 |
Est. primary completion date | December 20, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Age from 18 to 75 years; - Definite diagnosis of rectal NET less than 10mm; - Patients plan to receive either EMR-C or ESD treatment. Exclusion Criteria: - Serious comorbid diseases such as advanced malignant tumor and organ failure; - Patients received conventional EMR, snare electrotomy and no treatment; - Rectal NET with metastasis; - Pregnant patient; - Poor compliance |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Nanfang Hospital of Southern Medical University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | complete resection rate(R0 rate) | Complete resection was defined as negative horizontal and vertical margins of specimen. | within 14 days after procedure | |
Secondary | operating time | the time from endoscope in to endoscope out | intraoperative | |
Secondary | complications rate | Complications were defined as perforation or hemorrhage during or after operation. | within 14 days after procedure | |
Secondary | length of stay | calculated from the day of admission to day of discharge | within 14 days after procedure | |
Secondary | hospitalization cost | represent the hospital's costs of being hospitalized | within 14 days after procedure | |
Secondary | recurrence rate | a new rectal NET recurred confirmed by endoscopy and EUS | one year after procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05429216 -
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
|
N/A |